Hexvix Fluorescence Cystoscopy vs White Light Cystoscopy in Papillary Bladder Cancer

Phase 3, randomised, open-label trial of hexaminolevulinate in papillary urothelial carcinoma of the bladder (2 arms), sponsored by Photocure. Primary endpoints: Proportion of Patients With >= 1 Ta or T1 Tumor Detected With Blue Light and Not White Light at Day 0 and Comparison of the Proportions of Patients in the White Light Cystoscopy and Hexvix Groups Who Underwent TURB for a Histologically-confirmed Ta or T1 Tumor Who Had a Recurrence Within 9 Months. Started Jan 2005; status: completed.